The cost-effectiveness of mild hypercapnia after out-of-hospital cardiac arrest: a health economic evaluation alongside the TAME study.
Lee YY, Eastwood G, Bailey MJ, Bellomo R, Nichol AD, Parke RL, McGuinness S, Bernard S, Arabi YM, Capellier G, Chia YW, Grejs A, Hænggi M, Kutsogiannis D, Landoni G, Markota A, Nielsen N, Olasveengen T, Skrifvars MB, Taccone F, Wise MP, Higgins AM; TAME Study Investigators.
Lee YY, et al.
Resuscitation. 2025 Dec;217:110878. doi: 10.1016/j.resuscitation.2025.110878. Epub 2025 Oct 30.
Resuscitation. 2025.
PMID: 41176021
Free article.
Clinical Trial.
The Targeted Therapeutic Mild Hypercapnia after Resuscitated Cardiac Arrest (TAME) randomised clinical trial showed that targeted mild hypercapnia did not lead to better neurologic outcomes at 6 months compared to normocapnia after OHCA. We aimed to estimate the cost-effec …
The Targeted Therapeutic Mild Hypercapnia after Resuscitated Cardiac Arrest (TAME) randomised clinical trial showed that targeted mild hyper …